CRANBURY, N.J.--(BUSINESS WIRE)--VaxInnate Corporation today announced that Thomas Hofstaetter, PhD, who led Corporate Business Development at Wyeth Inc., has joined the company as Chief Operating Officer (COO). VaxInnate is a biotechnology company pioneering breakthrough technology for developing novel vaccines.
